← Back to Search

Thoracentesis QI Study

Minneapolis, MN
N/A
Waitlist Available
Led By Roy Cho, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after removing the thoracentesis catheter
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare 3 methods of draining fluid from the chest during therapeutic thoracentesis. Patients will be randomly assigned to manual aspiration, vacuum bottle drainage, or wall suction methods. The primary outcome is the amount of time the procedure takes, with secondary outcomes of pain and dyspnea scores.

See full description
Eligible Conditions
  • Pleural Effusion

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours post-procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours post-procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain and dyspnea scores- 24h post
Pain and dyspnea scores- 5m post
Pain and dyspnea scores- Baseline
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Manual aspirationActive Control1 Intervention
pleural fluid is drained using a standard thoracentesis kit and via a syringe and three-way stopcock
Group II: Wall suctionActive Control1 Intervention
pleural fluid is drained using a standard thoracentesis kit and by attaching tubing to wall suctioning set at -50 mmHg continuously
Group III: Vacuum bottle drainageActive Control1 Intervention
pleural fluid is drained using a standard thoracentesis kit and tubing that attaches to a glass vacuum container

Find a Location

Closest Location:University of Minnesota· Minneapolis, MN

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,454 Previous Clinical Trials
1,625,118 Total Patients Enrolled
Roy Cho, MDPrincipal InvestigatorUniversity of Minnesota
~25 spots leftby Feb 2026